Hair Drug Testing Global Market Report 2025

The hair drug testing market size has grown rapidly in recent years. It will grow from $1.87 billion in 2024 to $2.07 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth during the historic period is attributed to the rise in workplace drug testing programs, increasing prevalence of substance abuse, greater adoption of long-term detection methods, expansion of criminal justice drug testing, and growing awareness of drug-related health risks.

The hair drug testing market size is expected to see rapid growth in the next few years. It will grow to $3.09 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth during the forecast period is attributed to the rising demand for accurate and tamper-resistant testing, increasing use of drug testing in rehabilitation centers, greater emphasis on employee safety in high-risk industries, expansion of healthcare applications for drug detection, and increasing government regulations promoting drug-free environments. Key trends in the forecast period include technological advancements in drug testing methods, innovations in sample collection and processing, developments in laboratory automation systems, research and development for improved accuracy, and the integration of advanced data analytics in testing solutions.

Rising concerns about substance abuse are expected to drive the growth of the hair drug testing market. Substance abuse involves the harmful or hazardous use of psychoactive substances, including alcohol and drugs, leading to physical, mental, or social impairments. The increase in substance abuse is linked to stress and mental health issues, as individuals often use drugs or alcohol to cope with anxiety, depression, or life pressures. Hair drug testing provides a reliable long-term detection method, supporting early intervention, monitoring recovery progress, and preventing relapse. For example, in April 2025, the Centers for Disease Control and Prevention reported that in 2023, an estimated 48.5 million individuals aged 12 and older in the United States, representing 17.1% of the population, experienced a substance use disorder. This rising concern is contributing to the growth of the hair drug testing market.

Key companies in the hair drug testing market are focusing on innovative approaches, such as advanced reporting analytics, to improve accuracy, streamline result interpretation, and support informed decision-making. Advanced reporting analytics involves the use of sophisticated software and data analysis tools to organize, interpret, and visualize testing results, providing faster, more accurate, and actionable insights compared to traditional reporting methods. For instance, in March 2025, Psychemedics Corporation, a US-based public medical laboratory specializing in hair drug testing, launched its Quartile Reporting feature. This advancement allows organizations to compare individual results against a 12-month dataset of positive tests divided into four quartiles, lower, median, upper, and highest, offering clear context for better decision-making. By providing real-time analytics and detailed data trends, Quartile Reporting helps organizations make informed hiring, retention, and compliance decisions.

In April 2023, Phenna Group Holdings Limited, a UK-based testing, inspection, certification, and compliance company, acquired Cansford Laboratories Ltd for an undisclosed amount. The acquisition aimed to enhance Phenna Group’s health sciences platform by adding complementary services to its existing offerings. Cansford Laboratories Ltd is a UK-based company providing hair drug testing services.

Major players in the hair drug testing market are Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific, National Medical Services Inc., USA Mobile Drug Testing, DriverCheck Inc., MVZ Labor Dr. Limbach And Kollegen, Randox Testing Services, Phamatech Inc., The Drug Detection Agency, Accredited Drug Testing Inc., Crystal Health Group, AlphaBiolabs Ltd., Toxlogic Pty Ltd., American Screening Corporation Inc., Australian Workplace Drug Testing Services, DNA Forensics Laboratory Pvt. Ltd., US Health Testing, AMH Nationwide, and Brassets Group.

North America was the largest region in the hair drug testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hair drug testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The hair drug testing market research report is one of a series of new reports that provides hair drug testing market statistics, including hair drug testing industry global market size, regional shares, competitors with a hair drug testing market share, detailed hair drug testing market segments, market trends and opportunities, and any further data you may need to thrive in the hair drug testing industry. This hair drug testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Hair drug testing is a technique used to identify the presence of drugs or their metabolites in a person’s hair. It offers a long-term record of drug use, typically up to 90 days. The process involves analyzing a small hair sample, usually taken from the head or body. It is commonly employed in workplaces, legal proceedings, and rehabilitation programs due to its accuracy and resistance to tampering.

The primary product types in hair drug testing include kits, analyzers, and consumables. Kits are specialized diagnostic tools designed to detect drugs or their metabolites in hair samples, providing a reliable method to identify past substance use over an extended period. They are used to detect various substances such as cocaine, marijuana, opiates, amphetamines, and others. These products are applied in workplace drug testing, law enforcement, drug treatment, and other areas, serving end users including workplaces, criminal justice systems, drug treatment centers, hospitals, and more.

The countries covered in the hair drug testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hair drug testing market consists of revenues earned by entities by providing services such as laboratory testing services, on-site collection services, screening and verification services, and forensic and legal testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The hair drug testing market also includes sales of instant hair drug test strips, hair collection devices, and hair drug test panels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.